ABSTRACT
The 40th Annual J.P. Morgan Healthcare Conference was conducted as a virtual conference for the second consecutive year due to the COVID-19 pandemic. Being the largest investment symposium in the healthcare industry, the conference brought together thousands of investors around the globe and hundreds of companies from the whole global healthcare landscape, that includes pharmaceutical companies, medical device firms, healthcare service providers, and profit and not-for-profit organizations. This report covers a selection of company presentations given over the duration of the conference. Copyright © 2022 Clarivate
ABSTRACT
The 2022 American Academy of Neurology (AAN) annual meeting returned to in-person attendance for the first time in 2 years since the COVID-19 public health emergency began. AAN is the largest association of neurologists and neuroscience professionals with over 38,000 members. This meeting included plenary sessions and over 2,400 scientific s highlighting the latest scientific advancements in brain disease. Research and clinical trial updates were provided in many specific disease areas, including Parkinson???s, Huntington???s, amyotrophic lateral sclerosis, migraine, multiple sclerosis, epilepsy, narcolepsy, Alzheimer???s, and so on. Along with groundbreaking research in neurology, many presentations included the impact of COVID-19 on patients with these diseases and ongoing neurology clinical trials. This report highlights a selection of presentations about treatment updates provided during the conference.
ABSTRACT
The 57th Annual Meeting of the American Society of Clinical Oncology (ASCO) was held in a virtual setting due to the COVID-19 pandemic preventing the usual in-person event. The meeting continued its aim of providing the most up-to-date information relating to ongoing research into treatments of all forms of cancer with poster and oral sessions held with panel discussions and Q&A opportunities. This report highlights some of the important research presented throughout the meeting. © 2021 Clarivate Analytics
ABSTRACT
The Annual J.P. Morgan Healthcare Conference, usually held in San Francisco, California, reached its 39th edition this year, and due to the COVID-19 pandemic, was held virtually for the first time. It continued to maintain its position as the most informative healthcare investment conference, bringing together over 400 companies to showcase via recorded presentations their ongoing research to over 8,000 attendees and potential investors. This report covers a selection of company presentations given over the duration of the conference. Copyright © 2021 Clarivate Analytics.
ABSTRACT
The 21st World Vaccine Congress, held on May 4-6, 2021, virtually, was organized by Terrapinn and engaged academia, researchers, technology companies, pharmaceutical executives, scientists and military personnel in a 3-day discussion about the current state of global vaccine development. COVID-19 largely dominated panel discussions and presentations, comprising the majority of sessions. The meeting opened with the conference chair, Gregory Poland (Mayo Clinic), and subsequent presentations outlined ongoing clinical studies for vaccines to prevent COVID-19, including emerging technologies that could change the landscape of vaccine administration and the efficacy of vaccines against variants of concern. In addition to COVID-19, presenters offered results from studies of cancer vaccines for melanoma, human papillomavirus and glioblastoma and an update on a Food and Drug Administration-approved cholera vaccine under evaluation for use in pediatric patients. The entirety of day 3 consisted of panel discussions about COVID-19 vaccines for pediatric patients, tackling future pandemics, the threat of misinformation in a public health emergency, and the use of databases to streamline COVID-19 efforts. Dr. Poland provided take-home remarks that emphasized the need for preparedness and said, "While COVID-19 was a surprise, it should not have been a shock. We have been warned many times in many ways." He concluded that, moving forward, 2 significant cultural problems remain: "scientific illiteracy and the false notion of the democratization of expertise."
ABSTRACT
Participants from industry and academia virtually attended the 16th PEGS Annual Meeting held August 31, 2020, through September 4, 2020. PEGS 2020 was originally scheduled to be held in Boston, Massachusetts, May 4-8, 2020, but was postponed and held as a virtual summit due to public health concerns surrounding the SARS-CoV-2 pandemic. The PEGS 2020 program was organized in 9 streams: Engineering;oncology;immunotherapy;cell-based immunotherapy;analytical;expression;immunogenicity and bioassays;bioconjugates;and emerging therapeutics and technologies. This report summarizes presentations across these streams. © 2020 Clarivate Analytics
ABSTRACT
The American Association for Cancer Research (AACR) Annual Meeting is one of the most important events in the field of cancer research, covering all aspects and bringing together all players including physician-scientists and other healthcare professionals, cancer survivors, patients and advocates. Due to the global COVID-19 infection pandemic, the 111th Meeting, due to be held in San Diego, California, was adapted into 2 virtual meetings, the first held April 27-28 and the second part to be held June 22-24. The first part included oral and poster sessions, mainly on clinical trial data, with mini-symposia focused on basic and translational science and New Drugs on the Horizon symposia focused on disclosures of innovative small molecules and biologics for which phase I clinical trials have begun. This report covers some of the highlights from the presentations given as part of the Virtual Meeting I.
ABSTRACT
The ongoing COVID-19 pandemic has to date led to many conferences opting for a virtual experience, and, as such, the European Hematology Association (EHA)'s 25th Annual Congress, due to be held in Frankfurt, Germany, became EHA25 Virtual. The virtual congress continued the EHA Congress goal of bringing together hematologists worldwide to present and discuss new and ongoing developments in the field and provide online networking opportunities. Presentations were given in the usual settings of poster and oral sessions, including both live and recorded sessions, with the platform allowing for questions to be asked and responded to throughout the congress. Live Theme-of-the-Day sessions allowed Q&A opportunities via online chat. Additionally, a virtual exhibit hall was also created allowing online content from industry members, giving EHA25 Virtual a true congress feel. This report covers the highlights from poster and oral sessions on the latest developments in treatments of hematological diseases.
ABSTRACT
At the 56th Global Annual Meeting of the Drug Information Association (DIA), attendees met virtually during the height of the global COVID-19 pandemic for "rapid cross-stakeholder, cross-border collaboration" to support health worldwide. Sessions included presenters and speakers from regulatory, patient advocacy and academia sectors, with patients at the forefront of those discussions. This report covers various presentations and panel discussions from the 4-day meeting that focus on COVID-19, innovative trial designs spurred by a need to adapt amid a pandemic, digital health, novel products inspiring new regulatory standards, clinical trials, data collection and management, the need for more and better data and the ever-increasing importance of the patient perspective.